Article Details

Allogene Therapeutics (NASDAQ:ALLO) Reaches New 52-Week Low on Insider Selling

Retrieved on: 2022-12-21 06:25:14

Tags for this article:

Click the tags to see associated articles and topics

Allogene Therapeutics (NASDAQ:ALLO) Reaches New 52-Week Low on Insider Selling. View article details on HISWAI: https://reporter.am/2022/12/21/allogene-therapeutics-nasdaqallo-reaches-new-52-week-low-on-insider-selling.html

Excerpt

WINTON GROUP Ltd now owns 30,470 shares of the company's stock worth $278,000 after purchasing an additional 5,911 shares during the period.

Article found on: reporter.am

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up